Compare AU
Compare DRUG vs. MOGL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Montgomery Global Investment Portfolio (MOGL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | MOGL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 4 |
Median incremental investment | $967.00 | $295.25 |
Median investment frequency | Monthly | Fortnightly |
Median total investment | $1,882.65 | $13,168.41 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | MOGL | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | N/A |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | KKR & Co Inc Ordinary Shares (10.52 %) Amazon.com Inc (10.23 %) Blackstone Inc (9.48 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Communication Services (29.81 %) Financials (28.90 %) Information Technology (27.24 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (81.43 %) China (8.13 %) France (2.82 %) |
Management fee | 0.57 % | N/A |
Key Summary
DRUG | MOGL | |
|---|---|---|
Issuer | BetaShares | N/A |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | N/A |
Asset class | ETF | Stock |
Management fee | 0.57 % | N/A |
Price | $8.12 | $5.32 |
Size | $182.401 million | N/A |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 4.59 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 20/12/2017 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | MOGL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 4 |
Median incremental investment | $967.00 | $295.25 |
Median investment frequency | Monthly | Fortnightly |
Median total investment | $1,882.65 | $13,168.41 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | MOGL | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | MOGL |
|---|---|
Exposure to more markets and sectors | Exposure to 1 market and 1 sector only |
Lower price growth | Higher price growth |
Lower dividend/distribution yield | Higher dividend/distribution yield |